PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 12 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Ethyl acetate, ethanol, n-hexane extracts, and homopterocarpin exhibited antiplasmodial activity with low toxicity (SI ≥ 28.46) [PMID: 36789389]. Medicarpin (derived from homopterocarpin) showed an IC50 of 0.45 ± 0.35 µg/mL [PMID: 40596118].
Medicarpin demonstrated anticancer efficacy against Huh7it-1 cells with an IC50 of 34.32 ± 5.56 µg/mL [PMID: 40596118].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37848504 (2023) — Chromosome-scale genomes of five Hongmu species in Leguminosae. · Scientific data
- 2.PMID: 36789389 (2023) — In silico anti-SARS-CoV-2, antiplasmodial, antioxidant, and antimicrobial activities of crude extracts and homopterocarpin from heartwood of Pterocarpus macrocarpus Kurz. · Heliyon
- 3.PMID: 33366718 (2020) — The complete chloroplast genome sequence of Pterocarpus macrocarpus. · Mitochondrial DNA. Part B, Resources
- 4.PMID: 17345318 (1986) — Macrocarposide, a new isoflavanone c-glucoside from Pterocarpus macrocarpus heart wood. · Planta medica
- 5.PMID: 32466556 (2020) — Comparative Analyses of Five Complete Chloroplast Genomes from the Genus Pterocarpus (Fabacaeae).